Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Clinical
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
15 Sep 2021 - 16 Sep 2021
5th Annual Cell & Gene Therapy World Asia, virtual
14 Sep 2021
Clinical Trials in Rare Diseases Conference 2021, Europe and USA, virtual conference
09 September 2021
GenSight Biologics Announces Publication Analyzing Visual Parameters of ND4-LHON Subjects before LUMEVOQ® treatment in Phase III Trials
08 Sep 2021
Ophthalmology Futures Forums – Euro Retina Virtual Forum, September 8, 2021
06 September 2021
UK MHRA grants GenSight Biologics’ LUMEVOQ® ophthalmic gene therapy Promising Innovative Medicine designation
02 Sep 2021 - 04 Sep 2021
2021 ISGEDR Meeting (International Society for Genetic Eye Diseases & Retinoblastoma)
31 August 2021
GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®
20 Jul 2021
OIS European Innovation Showcase – Virtual
07 Jul 2021
French Retail Investors Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
09 Jul 2021
KOL Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
View previous 9 articles
1
2
3
4
5
6
7
8
9
…
14
View next 9 articles
Go back to the page of the page